Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
2008 Standout
Homocysteine and vascular disease
1999 Standout
Angiotensin, LDL peroxidation and atherosclerosis
1998
Antiatherosclerotic and Antioxidative Effects of Captopril in Apolipoprotein E-Deficient Mice
1998
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Homocysteine and coronary atherosclerosis
1996
Determination of layer-specific mechanical properties of human coronary arteries with nonatherosclerotic intimal thickening and related constitutive modeling
2005 Standout
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Nonfasting Plasma Total Homocysteine Levels and All-Cause and Cardiovascular Disease Mortality in Elderly Framingham Men and Women
1999
The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient Mice
1997
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease
2001
Homocysteine‐Lowering Therapy and Early Progression of Transplant Vasculopathy: A Prospective, Randomized, IVUS‐Based Study
2005
Polymorphisms in the CBS Gene Associated with Decreased Risk of Coronary Artery Disease and Increased Responsiveness to Total Homocysteine Lowering by Folic Acid
2000
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
2001
Cardiac calcification in adult hemodialysis patients
2002 Standout
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Objective assessment of the response to treatment of severe heart failure using a 9-minute walk test on a patient-powered treadmill
1996
Intake of Garlic and Its Bioactive Components
2001 Standout
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI
2000
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
The renin-angiotensin system in left ventricular remodeling
1996
Homocysteine and Risk of Ischemic Heart Disease and Stroke
2002 Standout
High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
1996
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
2000 Standout
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
2002 Standout
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
1997
Nitric oxide and the proliferation of vascular smooth muscle cells
1999
Atherosclerosis — An Inflammatory Disease
1999 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Induction of oxidative stress by homocyst(e)ine impairs endothelial function*
2001
Relationship of impairment induced by intracellular S‐adenosylhomocysteine accumulation with DNA methylation in human umbilical vein endothelial cells treated with 3‐deazaadenosine
2009
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Homocysteine and cardiovascular disease:
2002
Human tissue-engineered blood vessels for adult arterial revascularization
2006 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease
2004
Homocysteinemia as a risk factor for atherosclerosis: a review
1997
Atherosclerosis
2000 StandoutNature
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Homocysteine and atherosclerosis
1999
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Homocysteine and Atherothrombosis
1998 Standout
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage—foam cell accumulation independently of blood pressure and plasma lipids
1994
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study
1996
Mechanical properties of porcine and human arteries: implications for coronary anastomotic connectors
2003
Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure
2001
Generation of Nitrotyrosine Precedes Activation of Metalloproteinase in Myocardium of Hyperhomocysteinemic Rats
2002
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Protective Effect of Chronic Garlic Intake on Elastic Properties of Aorta in the Elderly
1997
Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy
2002
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model
1996
Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial.
2005
Long-Term Homocysteine-Lowering Treatment With Folic Acid Plus Pyridoxine Is Associated With Decreased Blood Pressure but Not With Improved Brachial Artery Endothelium-Dependent Vasodilation or Carotid Artery Stiffness
2001
Differential Distribution of Electrophysiologically Distinct Myocytes in Conduit and Resistance Arteries Determines Their Response to Nitric Oxide and Hypoxia
1996
Guidelines for the Primary Prevention of Stroke
2014 Standout
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
2006 Standout
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia
2001 StandoutNobel
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Coronary Plaque Disruption
1995 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Homocysteine and Cardiovascular Disease
1998 Standout
Exercise and Hypertension
2004 Standout
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
2004 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Stented Artery Flow Patterns and Their Effects on the Artery Wall
2006
Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.
1998
Nitric oxide‐mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease
2000
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study
1999
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel
Long‐term Effects of a Comprehensive Rehabilitation Programme after Myocardial Infarction
1996
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
1994
Repeated Oral Administration of High Doses of the Pomegranate Ellagitannin Punicalagin to Rats for 37 Days Is Not Toxic
2003 Standout
Works of A Friggi being referenced
Therapeutic Effects of Nitric Oxide-Donor Isosorbide Dinitrate on Atherosclerosis-Induced Alterations in Hemodynamics and Arterial Viscoelasticity Are Independent of the Wall Elastic Component
1996
Hemodynamics and Wall Mechanics after Stent Placement in Swine Iliac Arteries: Comparative Results from Six Stent Designs
1999
Effects of Cryopreservation on the Viscoelastic Properties of Human Arteries
1996
Effects of folate supplementation in hyperhomocysteinemic pigs
1999
Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs
1993
Control of the anti-thrombogenic endothelial cell defense by short- and long-term exposure of cultured endothelial cells to isosorbide nitrates
1988
Hyperhomocysteinemia-Induced Vascular Damage in the Minipig
1995
ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.
1993
Aorta viscoelasticity and arterial histopathology of atherosclerotic pigs treated by angiotensin converting enzyme inhibition
1991